| 1. |
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Ekberg, Anna, et al.
(författare)
-
Isoprene emission from wetland sedges
- 2009
-
Ingår i: Biogeosciences. - 1726-4189. ; 6:4, s. 601-613
-
Tidskriftsartikel (refereegranskat)abstract
- High latitude wetlands play an important role for the surface-atmosphere exchange of carbon dioxide (CO2) and methane (CH4), but fluxes of biogenic volatile organic compounds (BVOC) in these ecosystems have to date not been extensively studied. This is despite BVOC representing a measurable proportion of the total gaseous C fluxes at northern locations and in the face of the high temperature sensitivity of these systems that requires a much improved process understanding to interpret and project possible changes in response to climate warming. We measured emission of isoprene and photosynthetic gas exchange over two growing seasons (2005-2006) in a subarctic wetland in northern Sweden with the objective to identify the physiological and environmental controls of these fluxes on the leaf scale. The sedge species Eriophorum angustifolium and Carex rostrata were both emitters of isoprene. Springtime emissions were first detected after an accumulated diurnal mean temperature above 0 degrees C of about 100 degree days. Maximum measured growing season standardized (basal) emission rates (20 degrees C, 1000 mu mol m(-2) s(-1)) were 1075 (2005) and 1118 (2006) mu g Cm-2 (leaf area) h(-1) in E. angustifolium, and 489 (2005) and 396 (2006) mu g Cm(-2)h(-1) in C. rostrata. Over the growing season, basal isoprene emission varied in response to the temperature history of the last 48 h. Seasonal basal isoprene emission rates decreased with leaf nitrogen (N), which may be explained by the typical growth and resource allocation pattern of clonal sedges as the leaves age. The observations were used to model emissions over the growing season, accounting for effects of temperature history, links to leaf assimilation rate and the light and temperature dependencies of the cold-adapted sedges.
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Erzurumluoglu, A. Mesut, et al.
(författare)
-
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci
- 2020
-
Ingår i: Molecular Psychiatry. - : Nature Publishing Group. - 1359-4184 .- 1476-5578. ; 25:10, s. 2392-2409
-
Tidskriftsartikel (refereegranskat)abstract
- Smoking is a major heritable and modifiable risk factor for many diseases, including cancer, common respiratory disorders and cardiovascular diseases. Fourteen genetic loci have previously been associated with smoking behaviour-related traits. We tested up to 235,116 single nucleotide variants (SNVs) on the exome-array for association with smoking initiation, cigarettes per day, pack-years, and smoking cessation in a fixed effects meta-analysis of up to 61 studies (up to 346,813 participants). In a subset of 112,811 participants, a further one million SNVs were also genotyped and tested for association with the four smoking behaviour traits. SNV-trait associations with P < 5 × 10-8 in either analysis were taken forward for replication in up to 275,596 independent participants from UK Biobank. Lastly, a meta-analysis of the discovery and replication studies was performed. Sixteen SNVs were associated with at least one of the smoking behaviour traits (P < 5 × 10-8) in the discovery samples. Ten novel SNVs, including rs12616219 near TMEM182, were followed-up and five of them (rs462779 in REV3L, rs12780116 in CNNM2, rs1190736 in GPR101, rs11539157 in PJA1, and rs12616219 near TMEM182) replicated at a Bonferroni significance threshold (P < 4.5 × 10-3) with consistent direction of effect. A further 35 SNVs were associated with smoking behaviour traits in the discovery plus replication meta-analysis (up to 622,409 participants) including a rare SNV, rs150493199, in CCDC141 and two low-frequency SNVs in CEP350 and HDGFRP2. Functional follow-up implied that decreased expression of REV3L may lower the probability of smoking initiation. The novel loci will facilitate understanding the genetic aetiology of smoking behaviour and may lead to the identification of potential drug targets for smoking prevention and/or cessation.
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
